Stay updated on GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Sign up to get notified when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.

Latest updates to the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page
- Check5 days agoChange DetectedRevision banner updated from v3.4.0 to v3.4.1, a minor version change in the footer that does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded a glossary display and new QC/compliance notes (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the older QC wording, No FEAR Act data wording, and Revision: v3.3.4.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedDifference0.2%

- Check76 days agoChange DetectedRevision from v3.2.0 to v3.3.2; no changes to trial details or page content are evident in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoved the government funding/operational status notice from the page; core study details and related content appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.